Study to Evaluate ARD-101 in Adults With Obesity

NCT05121441 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: ARD-101
DRUG: Placebo

Sponsor

Aardvark Therapeutics, Inc.

Collaborators

[object Object]